Latest Autism Stories
The Focus Autism Foundation Investigates Autism Speaks' Shifting Stance on Vaccine Safety Research WATCHUNG, N.J., July 10, 2014 /PRNewswire-iReach/ -- There was a time when the world's
First series of its kind - video series of 26 short, single-issue videos offering “Real Life Tips” to help families navigate these challenges.
NextCODE capabilities will power ACoRD/UCD leadership in sequence-based diagnostics and large-scale whole-genome discovery efforts in pediatric disorders CAMBRIDGE,
First connection between a genetic event, physical features and autism SEATTLE, July 3, 2014 /PRNewswire/ -- A researcher at Seattle Children's Hospital and Research Institute has
Autism Speaks Chief Science Officer Pledges to Put Science to Work for Families New York, NY (PRWEB) July 02, 2014 Autism Speaks, the world’s leading
The Remote Clinical Services program provides quality therapy and supervision to individuals with autism spectrum disorder, regardless of where they live. Los
--$100,000 World of Difference grant will fund research lacking today BLOOMFIELD, Conn., July 1, 2014 /PRNewswire/ -- A Cigna Foundation grant to Achilles International will
UCSF shows success of randomized clinical trial for kids with autism, establishing it as a time and cost effective tool.
The Sensory Processing Disorder (SPD) Foundation has just released preliminary results documenting the effectiveness of the STAR treatment model for children with SPD.
Mental Health Research Nonprofit Receives Leadership Award Chicago, IL (PRWEB) June 30, 2014 Easter Seals honored the Brain & Behavior Research Foundation
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.
More Images (1 images) »